138 related articles for article (PubMed ID: 34391933)
1. Inhibition of N-acylethanolamine-hydrolyzing acid amidase reduces T cell infiltration in a mouse model of multiple sclerosis.
Sgroi S; Romeo E; Fruscia PD; Porceddu PF; Russo D; Realini N; Albanesi E; Bandiera T; Bertozzi F; Reggiani A
Pharmacol Res; 2021 Oct; 172():105816. PubMed ID: 34391933
[TBL] [Abstract][Full Text] [Related]
2. Combined in vivo effect of N-acylethanolamine-hydrolyzing acid amidase and glycogen synthase kinase-3β inhibition to treat multiple sclerosis.
Sgroi S; Romeo E; Albanesi E; Piccardi F; Catalano F; Debellis D; Bertozzi F; Reggiani A
Biomed Pharmacother; 2024 Jun; 175():116677. PubMed ID: 38701570
[TBL] [Abstract][Full Text] [Related]
3. N-Acylethanolamine Acid Amidase contributes to disease progression in a mouse model of multiple sclerosis.
Pontis S; Palese F; Summa M; Realini N; Lanfranco M; De Mei C; Piomelli D
Pharmacol Res; 2020 Oct; 160():105064. PubMed ID: 32634582
[TBL] [Abstract][Full Text] [Related]
4. N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice.
Bottemanne P; Guillemot-Legris O; Paquot A; Masquelier J; Malamas M; Makriyannis A; Alhouayek M; Muccioli GG
Neurotherapeutics; 2021 Jul; 18(3):1815-1833. PubMed ID: 34235639
[TBL] [Abstract][Full Text] [Related]
5. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
[TBL] [Abstract][Full Text] [Related]
6. Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions.
Dagkonaki A; Avloniti M; Evangelidou M; Papazian I; Kanistras I; Tseveleki V; Lampros F; Tselios T; Jensen LT; Möbius W; Ruhwedel T; Androutsou ME; Matsoukas J; Anagnostouli M; Lassmann H; Probert L
Front Immunol; 2020; 11():575451. PubMed ID: 33329540
[TBL] [Abstract][Full Text] [Related]
7. Involvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in rats.
Yin L; Chen Y; Qu Z; Zhang L; Wang Q; Zhang Q; Li L
J Neuroimmunol; 2014 Sep; 274(1-2):28-37. PubMed ID: 25012120
[TBL] [Abstract][Full Text] [Related]
8. Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord.
Chechneva OV; Mayrhofer F; Daugherty DJ; Pleasure DE; Hong JS; Deng W
Neurobiol Dis; 2011 Oct; 44(1):63-72. PubMed ID: 21704706
[TBL] [Abstract][Full Text] [Related]
9. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling.
Zhang D; Qiao L; Fu T
Biomed Pharmacother; 2020 May; 125():109528. PubMed ID: 32106388
[TBL] [Abstract][Full Text] [Related]
10. Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway.
Li G; Yamasaki R; Fang M; Masaki K; Ochi H; Matsushita T; Kira JI
Sci Rep; 2018 Jan; 8(1):1933. PubMed ID: 29386552
[TBL] [Abstract][Full Text] [Related]
11. Early pregnancy factor suppresses the infiltration of lymphocytes and macrophages in the spinal cord of rats during experimental autoimmune encephalomyelitis but has no effect on apoptosis.
Athanasas-Platsis S; Zhang B; Hillyard NC; Cavanagh AC; Csurhes PA; Morton H; McCombe PA
J Neurol Sci; 2003 Oct; 214(1-2):27-36. PubMed ID: 12972385
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing the mTOR-STAT3 Pathway.
Hou H; Miao J; Cao R; Han M; Sun Y; Liu X; Guo L
Neurochem Res; 2017 Oct; 42(10):2831-2840. PubMed ID: 28600752
[TBL] [Abstract][Full Text] [Related]
13. Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice.
Valero-Esquitino V; Lucht K; Namsolleck P; Monnet-Tschudi F; Stubbe T; Lucht F; Liu M; Ebner F; Brandt C; Danyel LA; Villela DC; Paulis L; Thoene-Reineke C; Dahlöf B; Hallberg A; Unger T; Sumners C; Steckelings UM
Clin Sci (Lond); 2015 Jan; 128(2):95-109. PubMed ID: 25052203
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside-Re inhibits experimental autoimmune encephalomyelitis as a mouse model of multiple sclerosis by downregulating TLR4/MyD88/NF-κB signaling pathways.
Oh J; Kwon TW; Choi JH; Kim Y; Moon SK; Nah SY; Cho IH
Phytomedicine; 2024 Jan; 122():155065. PubMed ID: 37856989
[TBL] [Abstract][Full Text] [Related]
15. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD
Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in EAE reveal common and distinct cellular and molecular components.
Wiedrick J; Meza-Romero R; Gerstner G; Seifert H; Chaudhary P; Headrick A; Kent G; Maestas A; Offner H; Vandenbark AA
Cell Immunol; 2021 Jan; 359():104242. PubMed ID: 33190849
[TBL] [Abstract][Full Text] [Related]
17. Effects of Bu Shen Yi Sui Capsule on Th17/Treg cytokines in C57BL/6 mice with experimental autoimmune encephalomyelitis.
Zheng Q; Yang T; Fang L; Liu L; Liu H; Zhao H; Zhao Y; Guo H; Fan Y; Wang L
BMC Complement Altern Med; 2015 Mar; 15():60. PubMed ID: 25887665
[TBL] [Abstract][Full Text] [Related]
18. Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase.
Hao W; Luo Q; Menger MD; Fassbender K; Liu Y
Front Immunol; 2021; 12():792465. PubMed ID: 34975892
[TBL] [Abstract][Full Text] [Related]
19. Treatment with the antipsychotic agent, risperidone, reduces disease severity in experimental autoimmune encephalomyelitis.
O'Sullivan D; Green L; Stone S; Zareie P; Kharkrang M; Fong D; Connor B; La Flamme AC
PLoS One; 2014; 9(8):e104430. PubMed ID: 25116424
[TBL] [Abstract][Full Text] [Related]
20. Piperlongumine attenuates experimental autoimmune encephalomyelitis through inhibition of NF-kappaB activity.
Gu SM; Yun J; Son DJ; Kim HY; Nam KT; Kim HD; Choi MG; Choi JS; Kim YM; Han SB; Hong JT
Free Radic Biol Med; 2017 Feb; 103():133-145. PubMed ID: 28011150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
